ACA Pharma: team@acapharma.net Azurity Pharmaceuticals: media@azurity.com ...
Prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI.
BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
The launch of Pixxoscan expands GE HealthCare’s portfolio of Magnetic Resonance Imaging (MRI) contrast agents, now offering two leading macrocyclic molecules to customers - Clariscan (gadoteric acid) ...
Bayer revealed first results of the pediatric study from the pivotal clinical development program QUANTI for its low-dose MRI contrast agent QUANTI Pediatric evaluated the pharmacokinetics and safety ...
You are also right that the iodine-containing dye from CT scans can precipitate hyperthyroidism in a person who is destined to get it. However, the risk of this occurring is low. There is no increased ...
ISMI offers a radiologist-led Full-Body MRI in Montreal to identify life-saving findings, detect health risks, and support ...
(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain--the Swoop (R) system--today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback